1. Activist Shareholder urges Allergan to negotiate with Valeant

    Activist Shareholder urges Allergan to negotiate with Valeant

    New York hedge fund manager William Ackman, who is teaming up with Valeant Pharmaceuticals in a $48 billion hostile bid for Botox maker Allergan, sent a letter Monday to Allergan’s top outside board member to urge that the Irvine-based company enter negotiations right away...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content
  2. Topics Mentioned